TP53 and non-small cell lung carcinoma: Despite the TP53 and ATM comutation being associated with increasing TMBs in 5 large independent NSCLC cohorts, the small number of TP53 and ATM mutation tumors and few patients who received ICIs in the MSKCC23 and POPLAR4 and OAK20 cohorts with a recorded survival advantage were not well reflected in the Kaplan-Meier survival analysis.